FY-2013 Top 20 Commercially Successful Inventions
(based on royalties on product sales)
VACCINES & THERAPEUTICS | |||
Rank | |||
1 | Novel Protease Inhibitor for Treatment of Drug-Resistant HIV-1 | Erickson et al. | NCI |
2 | HPV Vaccines Based Upon Recombinant Papillomavirus Capsid Proteins | Lowy et al. | NCI |
3 | Monoclonal Antibody for Treatment of RSV | Murphy et al. | NIAID |
6 | Vaccinia Virus Vector Used in Biologicals/Vaccines | Moss et al. | NCI |
9 | Conjugate Vaccine for Neisseria meningitidis | Gu et al. | NIDCD |
11 | Paclitaxel as a Cancer Treatment | Wilson et al. | NIAID |
12 | Proteosome Inhibitor for Treatment of Multiple Myeloma | Gupta et al. | NCI |
DIAGNOSTICS | |||
Rank | |||
4 | Serological Detection of Antibodies and Nucleic Acid Detection of HIV-1 | Gallo et al. | NCI |
5 | DNA Probe for Breast Cancer Diagnosis (HER-2) | King et al. | NCI |
8 | Breast and Ovarian Cancer Screening Test (BRAC-1) | Wiseman et al. | NIEHS |
10 | Genoyping of HIV Protease Gene | Oroszlan et al. | NCI |
19 | Diagnostic for Norwalk-like Virus | Green et al. | NIAID |
INSTRUMENTATION & DEVICES | |||
Rank | |||
7 | Diffusion Tensor Magnetic Resonance Imaging | Basser et al. | NICHD |
13 | Paclitaxel-Eluting Peripheral Stent System | Kinsella et al. | NIA |
15 | Laser Capture Microdissection | Liotta et al. | NCI |
18 | Digital PCR | Silver et al. | NIAID |
RESEARCH MATERIALS | |||
Rank | |||
14 | Purified Transforming Growth Factor Beta (TGF-beta) | Sporn et al. | NCI |
16 | Neutrophil Chemotactic Factor (IL-8) | Matsushima et al. | NCI |
17 | Monoclonal Antibodies to CD25, CD69, CD90, and LY6A/E | Shevach | NIAID |
20 | Monoclonal Antibody Reactive with Human Breast Cancer (TAG72) | Schlom et al. | NCI |